Media Coverage
3 March, 2021
How medical data can be safely shared between research units is a highly topical issue.
11 September, 2020
Scientists are beginning to study the almost miraculous diversity of immune cells generated by a process of genetic recombination called V(D)J, in which the body joins together three components to make receptors that can tackle new pathogens
25 August, 2020
The international iReceptor Plus consortium has gathered data of almost 200 million sequences of T and B cell receptor repertoires from COVID-19 patients. It is now offering its technology tools and infrastructure to share and analyze this unprecedented data resource with the scientific community, drug companies and researchers.
25 August, 2020
iReceptor+, an international consortium funded by the EU and Canada, is building a genetic database of immune cell receptors from Covid-19 patients. It already contains 200m DNA sequences provided by seven research teams in different countries.
17 August, 2020
Le dépôt de données sur la COVID-19 a accru de manière magistrale la visibilité et l’usage de la plateforme iReceptor, si bien qu’au début de juillet 2020, on enregistrait plus de nouveaux utilisateurs qu’on le fait normalement en six mois.
3 August, 2020
The international consortium is now offering its technology tools and infrastructure to share and analyze this unprecedented data resource with the scientific community, drug companies and researchers.
31 July, 2020
The iReceptor Plus Consortium said this week it is making nearly 200 million immune sequences from COVID-19 patients freely available to researchers worldwide.
27 July, 2020
In an exclusive interview, Technology Networks spoke with Felix Breden, scientific manager at iReceptor Plus, to learn more about the iReceptor Plus Gateway – a repertoire of almost 20000 million T and B cell receptor sequences from COVID-19 patients.
6 April, 2020
iReceptor Plus to Offer Tools for Sharing antibody and T-cell Receptor Sequencing Data from COVID-19 Patients
The iReceptor Plus project is currently building a technological platform with accompanying bioinformatics and machine learning tools to facilitate sharing and joint research of specific immunological data for the purpose of basic research as well as developing new therapeutics and vaccines for infectious diseases, autoimmune diseases and cancer.
30 January, 2019
iReceptor Plus Consortium Wants to Improve Immunological Data Sharing
The nascent iReceptor Plus Consortium, funded by €8.4 million (about $9.6 million) in awards from the European Union and the Canadian government, has the broad mandate of promoting integration and sharing of human immunological data. The hope is that the four-year effort will yield better understanding of immune responses and lead to new therapeutic targets for drug developers and clinicians.
17 January, 2019
EU and Canada award €8.4 million to ease genomic and health data sharing
The four-year project aims to develop an innovative platform to integrate distributed repositories of Adaptive Immune Receptor Repertoire sequencing (AIRR-seq) data for enabling improved personalized medicine and immunotherapy in cancer, inflammatory and autoimmune diseases, allergies and infectious diseases.
16 January, 2019
New project receives €8.65 million from EU and Canada to ease genomic, health data sharing
iReceptor Plus will enable researchers around the world to share and analyze huge immunological datasets taken from healthy and ill patients that have been sequenced and stored in databanks in multiple countries.
16 January, 2019
Immunological Data Sharing Consortium Wins €8.4M Award From EU, Canada
The newly launched iReceptor Plus Consortium has received a total of €8.4 million ($9.6 million) in awards from the European Union and the Canadian government to promote integration and sharing of human immunological data.
15 January, 2019
iReceptor Bags $9.6M in International Funding for Data Sharing Platform
The iReceptor Plus consortium, which is composed of more than 20 partners from nine countries, was granted approximately $9.6 million by the European Union and the Canadian government to promote human immunological data storage, integration and controlled sharing for clinical and scientific purposes, according to the company.
15 January, 2019
Health data consortium receives €8m EU backing in push towards personalised medicine
The iReceptor Plus consortium, made up of more than 20 partners from around the globe, has received €8.4m ($9.6m) in investment from the European Union and Canadian government as it pushes for advancement in human immunological data storage, integration and sharing across the healthcare industry.
14 January, 2019
EU, CANADA AWARD €8.4M. TO ISRAELI-LED HEALTH DATA PROJECT
The project received €7.85 million ($9m.) from the EU through its Horizon 2020 research and innovation program, of which Israel is a member, and a further €800,000 ($917,000) from the Canadian gov’t.
14 January, 2019
האיחוד האירופי וקנדה העניקו 8.65 מיליון יורו לפרויקט בהובלה ישראלית לקידום שיתוף מידע גנומי הקשור למערכת החיסון
מאגד המחקר איירספטור פלוס, הכולל עשרים שותפים מישראל, אירופה וצפון אמריקה, מיועד לקדם את אחסון הנתונים, אינטגרציה ושיתוף רצפים גנטיים, הקשורים למערכת החיסון במטרה לאפשר רפואה מותאמת אישית